Nir Kugelman

Dr. Nir Kugelman


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2021 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
NKNir Kugelman
Nir Kugelman
CNChen Nahshon
Chen Nahshon
PSPninit Shaked-Mishan
Pninit Shaked-Mishan
NCNadav Cohen
Nadav Cohen
MSMaayan Lahav Sher
Maayan Lahav Sher
RKReuven Kedar
Reuven Kedar
COVID-19 can lead to severe respiratory disease in pregnant women as well as quicker disease progression and higher rates of intensive care unit admissions than in the general population.1 It has been suggested that pregnancies complicated by COVID-19 have a higher risk for preterm birth, cesarean delivery, fetal distress, preeclampsia,2 and perinatal death.3 The chance of children becoming infected with COVID-19 is similar to that for adults; however, disease in children is usually more subtle.4,5 A severe infection in neonates and infants is uncommon5 despite the suboptimal defense of their humoral immune system.6 Several studies have shown that SARS-CoV-2 immunoglobulin G (IgG) antibodies are transferred through breast milk.7 However, IgG antibodies were not detected in the plasma of infants whose mothers were vaccinated during lactation.8

2 November 2020 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
NKNir Kugelman
Nir Kugelman
OLOfer Lavie
Ofer Lavie
WAWisam Assaf
Wisam Assaf
NCNadav Cohen
Nadav Cohen
LSLena Sagi-Dain
Lena Sagi-Dain
YSYakir Segev
Yakir Segev
The COVID-19 outbreak caused persons to be reluctant to seek medical care due to fear of contracting the infection. To evaluate the effect of the COVID-19 pandemic on admission rates to the deliver...

27 May 2022 in Obstetrics & Gynecology
Verified
Journal Article
Closed access
NKNir Kugelman
Nir Kugelman
CNChen Nahshon
Chen Nahshon
PSPninit Shaked-Mishan
Pninit Shaked-Mishan
SKShiran Kleifeld
Shiran Kleifeld
NCNadav Cohen
Nadav Cohen
SRShlomit Riskin-Mashiah
Shlomit Riskin-Mashiah
OBJECTIVE: To evaluate maternal and neonatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) antibody levels at birth after a third (booster) dose of the Pfizer-BioNTech messenger RNA (Pfizer) coronavirus disease 2019 (COVID-19) vaccine during the second trimester of pregnancy, and compare them with those in women who received two vaccine doses during the second trimester. METHODS: We conducted a prospective cohort study of women admitted to the delivery ward at a single center who received the third Pfizer COVID-19 vaccine dose (booster group) at 17–30 weeks of pregnancy and who did not have previous SARS-CoV-2 infection. Maternal and neonatal antibody levels were measured on admission for delivery and in the umbilical cord blood after birth. Antibody levels for the booster group were compared with those in a historical control group of pregnant women who received their second vaccine dose (two-dose group) within the same gestational age window. RESULTS: Between October 2021 and February 2022, antibody levels were measured in 121 women and 109 neonates at a mean±SD of 15.3±3.9 weeks after booster vaccination. Neonatal titers measured two times higher than maternal titers, with inverse correlation between maternal and neonatal titers at birth and time interval from third vaccination. The two-dose group included 121 women and 107 neonates, with antibody levels measured at a mean±SD of 14.6±2.6 weeks after the second dose. Median [interquartile range] maternal antibody titers were higher in the booster group (4,485 [2,569–9,702] AU/mL) compared with the two-dose group (1,122 [735–1,872] AU/mL) (P<.001). Furthermore, neonatal antibody titers were higher in the booster group (8,773 [5,143–18,830] AU/mL) compared with the two-dose group (3,280 [2,087–5,754] AU/mL) (P<.001). CONCLUSION: Maternal and neonatal SARS-CoV-2 IgG antibody titers after second-trimester maternal Pfizer COVID-19 vaccination were significantly higher after the booster dose compared with the two-dose vaccination series. Although there is uncertainty as to whether antibody levels correlate with protection, these data support the importance of booster vaccination during pregnancy to restore maternal and neonatal protection against COVID-19.

13 December 2022 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
NKNir Kugelman
Nir Kugelman
ARArieh Riskin
Arieh Riskin
RKReuven Kedar
Reuven Kedar
SRShlomit Riskin‐Mashiah
Shlomit Riskin‐Mashiah

30 May 2022 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
NKNir Kugelman
Nir Kugelman
CNChen Nahshon
Chen Nahshon
PSPninit Shaked-Mishan
Pninit Shaked-Mishan
NCNadav Cohen
Nadav Cohen
MSMaayan Lahav Sher
Maayan Lahav Sher
SRShlomit Riskin-Mashiah
Shlomit Riskin-Mashiah

19 March 2022 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
IMItai Margulis
Itai Margulis
RCRaanan Cohen-Kerem
Raanan Cohen-Kerem
ARAriel Roitman
Ariel Roitman
HGHadar Gez-Reder
Hadar Gez-Reder
AAAriel Aviram
Ariel Aviram
IDIlana Doweck
Ilana Doweck
Objective: To examine associations of laboratory and imaging data with diagnostic parameters of necrotizing otitis externa (NOE) and its severity, and to compare between bacterial and fungal infections. Methods: Records of patients diagnosed with NOE during 2010–2018 at the Department of Otolaryngology, Head and Neck Surgery were reviewed retrospectively for demographics; disease characteristics; and laboratory, scintigraphy, and imaging results. Results: Of 48 patients with NOE, the mean age is 73±11.6 years; 32 (67%) were males; 83% had diabetes mellitus. Common pathogens were pseudomonas (49%) and fungi (33%). Sensitivities of the technetium-scan (SPECT ratio ≥1.5), temporal bone computed tomography (CT), and gallium-scan (SPECT ratio ≥1.3) were: 78.7%, 48.8%, and 31.4%, respectively. Gallium-scan results correlated positively with CT bone involvement (p=0.002) and hospital length of stay (p=0.0014). C-reactive protein (CRP) level correlated with hospital length of stay (p=0.028) and positive technetium-scan results (p=0.012). Fungal infection had a higher technetium SPECT ratio (2.16 vs. 1.77, p=0.04), gallium SPECT ratio (1.4 vs. 1.2, p=0.02), longer duration of systemic treatment (87.4 vs. 37.9 days, p=0.014), and longer hospital length of stay (31.6 vs. 15.2 days, p=0.004) compared to non-fungal infection. Eight (17%) patients had responded poorly to treatment. Fungal pathogens, facial nerve paresis, extra-auricular, and bilateral disease were more prevalent among the non-responders. Conclusion: The technetium scan has higher sensitivity than temporal bone CT for diagnosing NOE. The gallium scan and CRP correlated well with hospital length of stay. A high rate of fungal infection was found, with significantly higher technetium and gallium SPECT ratios and worse outcome compared to bacterial infection. Fungal NOE remains therapeutically challenging.